These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33450359)

  • 1. FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.
    Yang Y; Li S; Li B; Li Y; Xia K; Aman S; Yang Y; Ahmad B; Zhao B; Wu H
    Cancer Lett; 2021 Apr; 502():108-119. PubMed ID: 33450359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
    Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
    J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells.
    Stein RA; Gaillard S; McDonnell DP
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):106-12. PubMed ID: 19429439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha.
    Barry JB; Giguère V
    Cancer Res; 2005 Jul; 65(14):6120-9. PubMed ID: 16024613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.
    Chisamore MJ; Cunningham ME; Flores O; Wilkinson HA; Chen JD
    PLoS One; 2009 May; 4(5):e5624. PubMed ID: 19462000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
    Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
    PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.
    Chen Y; Zhou Y; Han F; Zhao Y; Tu M; Wang Y; Huang C; Fan S; Chen P; Yao X; Guan L; Yu AM; Gonzalez FJ; Huang M; Bi H
    Theranostics; 2020; 10(16):7193-7210. PubMed ID: 32641987
    [No Abstract]   [Full Text] [Related]  

  • 10. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer.
    Wang L; Yang M; Jin H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
    Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
    J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway.
    Zhao X; Wang X; Li Q; Chen W; Zhang N; Kong Y; Lv J; Cao L; Lin D; Wang X; Xu G; Wu X
    Cell Death Dis; 2018 Jan; 9(2):46. PubMed ID: 29352142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha.
    Huss JM; Kopp RP; Kelly DP
    J Biol Chem; 2002 Oct; 277(43):40265-74. PubMed ID: 12181319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
    Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
    Vargas G; Bouchet M; Bouazza L; Reboul P; Boyault C; Gervais M; Kan C; Benetollo C; Brevet M; Croset M; Mazel M; Cayrefourcq L; Geraci S; Vacher S; Pantano F; Filipits M; Driouch K; Bieche I; Gnant M; Jacot W; Aubin JE; Duterque-Coquillaud M; Alix-Panabières C; Clézardin P; Bonnelye E
    Oncogene; 2019 Feb; 38(7):950-964. PubMed ID: 30478447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform.
    Kammerer M; Gutzwiller S; Stauffer D; Delhon I; Seltenmeyer Y; Fournier B
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):150-60. PubMed ID: 23403054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.
    Ueda T; Nagamachi A; Takubo K; Yamasaki N; Matsui H; Kanai A; Nakata Y; Ikeda K; Konuma T; Oda H; Wolff L; Honda Z; Wu X; Helin K; Iwama A; Suda T; Inaba T; Honda H
    Blood; 2015 May; 125(22):3437-46. PubMed ID: 25872778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol as an Endogenous Ligand of ERRα Promotes ERRα-Mediated Cellular Proliferation and Metabolic Target Gene Expression in Breast Cancer Cells.
    Ghanbari F; Mader S; Philip A
    Cells; 2020 Jul; 9(8):. PubMed ID: 32717915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.